Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Covenant Logistics (CVLG) Asset Writedowns and Impairment (2016 - 2020)

Covenant Logistics (CVLG) has disclosed Asset Writedowns and Impairment for 11 consecutive years, with $31000.0 as the latest value for Q4 2020.

  • On a quarterly basis, Asset Writedowns and Impairment changed N/A to $31000.0 in Q4 2020 year-over-year; TTM through Dec 2021 was $31000.0, a 99.88% decrease, with the full-year FY2025 number at $6.5 million, changed N/A from a year prior.
  • Asset Writedowns and Impairment was $31000.0 for Q4 2020 at Covenant Logistics, down from $26.2 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $26.2 million in Q2 2020 to a low of -$334000.0 in Q2 2016.
  • A 5-year average of $1.6 million and a median of $32000.0 in 2019 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: crashed 33500.0% in 2016, then surged 81928.12% in 2020.
  • Covenant Logistics' Asset Writedowns and Impairment stood at $290000.0 in 2016, then fell by 26.55% to $213000.0 in 2017, then plummeted by 178.87% to -$168000.0 in 2018, then skyrocketed by 119.05% to $32000.0 in 2019, then fell by 3.12% to $31000.0 in 2020.
  • Per Business Quant, the three most recent readings for CVLG's Asset Writedowns and Impairment are $31000.0 (Q4 2020), $26.2 million (Q2 2020), and $320000.0 (Q1 2020).